Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 AUD | +10.29% | +20.97% | +50.00% |
05:54am | Firebrick Pharma Appoints Auditor | MT |
Apr. 17 | Firebrick Pharma's Nasodine Nasal Spray Enters US Market | MT |
Sales 2022 | 1.08M 718K | Sales 2023 | 22.55K 14.95K | Capitalization | 27.32M 18.11M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.99M | Net income 2023 | -6M -3.98M | EV / Sales 2022 | 34.7 x |
Net cash position 2022 | 7.15M 4.74M | Net cash position 2023 | 2.35M 1.56M | EV / Sales 2023 | 1,107 x |
P/E ratio 2022 |
-8.13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.97% |
1 day | +10.29% | ||
1 week | +20.97% | ||
Current month | +19.05% | ||
1 month | +33.93% | ||
3 months | +38.89% | ||
6 months | +78.57% | ||
Current year | +50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Goodall
FOU | Founder | - | 12-04-11 |
Chief Executive Officer | 70 | 12-04-11 | |
Kavi Bekarma
DFI | Director of Finance/CFO | - | 23-01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Gardner
BRD | Director/Board Member | 73 | 20-11-12 |
Richard Treagus
BRD | Director/Board Member | 58 | 22-05-31 |
Chief Executive Officer | 70 | 12-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.075 | +10.29% | 290 282 |
24-05-03 | 0.068 | +6.25% | 682,540 |
24-05-02 | 0.064 | +1.59% | 63,085 |
24-05-01 | 0.063 | 0.00% | 136,474 |
24-04-30 | 0.063 | +8.62% | 29,708 |
Delayed Quote Australian S.E., May 06, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+50.00% | 8.06M | |
+30.79% | 662B | |
+21.96% | 546B | |
-5.28% | 359B | |
+16.87% | 323B | |
+4.72% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.00% | 167B |
- Stock Market
- Equities
- FRE Stock